Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress.
Saeideh NourmohammadiSanaz YousefiMahboubeh ManouchehrabadiMona FarhadiZahra AziziAnahita Torkaman-BoutorabiPublished in: BMC complementary medicine and therapies (2022)
Collectively, our findings suggest that thymol exerts protective effects, possibly related to an anti-oxidation mechanism, in these in vitro and in vivo models of Parkinson's disease.